Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12610000989044
Ethics application status
Approved
Date submitted
14/04/2010
Date registered
16/11/2010
Date last updated
16/11/2010
Type of registration
Retrospectively registered
Titles & IDs
Public title
Trial of an injection to reduce shoulder pain for people with Motor Neurone Disease
Query!
Scientific title
Suprascapular nerve block for the treatment of shoulder pain in patients with Motor Neurone Disease (MND)
Query!
Secondary ID [1]
251619
0
nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Motor Neurone Disease
257166
0
Query!
Condition category
Condition code
Neurological
257315
257315
0
0
Query!
Neurodegenerative diseases
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
A single injection of 10mls of 0.5% bupivocaine and 40 mg of depomedrol into the suprascapular fossa.
Query!
Intervention code [1]
256313
0
Treatment: Drugs
Query!
Comparator / control treatment
A placebo injection of 5 mls of normal saline injected subcutaneously.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
258222
0
Proposed outcome measures include a 100 point visual analogue pain scale (VAS).In order to achieve a clinically and statistically significant difference between the two groups, a 10 point difference is required on the VAS.
Query!
Assessment method [1]
258222
0
Query!
Timepoint [1]
258222
0
Baseline, 1 week, 6 weeks, 12 weeks.
Query!
Primary outcome [2]
258254
0
The shoulder pain and disability index (SPADI) .
Query!
Assessment method [2]
258254
0
Query!
Timepoint [2]
258254
0
Baseline, 1 week, 6 weeks, 12 weeks.
Query!
Secondary outcome [1]
263879
0
Nil
Query!
Assessment method [1]
263879
0
Query!
Timepoint [1]
263879
0
Nil
Query!
Eligibility
Key inclusion criteria
All patients with MND and shoulder pain will be considered for the study.
Query!
Minimum age
No limit
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Exclusion criteria will include those patients with an expected life span less than the anticipated follow up period (12 weeks) and/or those already in significant respiratory distress.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Patients will be invited to participate in the study and then be followed up by an observer blinded to the intervention type over a period of 12 weeks. Patients will be randomized into those receiving the Suprascapular Nerve Block (SSNB) and usual care and those receiving a placebo injection plus usual care. Numbered sealed opaque envelopes with either treatment or placebo inside will be used and drawn randomly by the person administering the treatment.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using numbered sealed opaque envelopes with either treatment or placebo inside and drawn randomly by the person administering the treatment.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
12/03/2010
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
80
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
256814
0
Charities/Societies/Foundations
Query!
Name [1]
256814
0
Foundation Daw Park
Query!
Address [1]
256814
0
Daws Road
Daw Park SA 5041
Query!
Country [1]
256814
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Repatriation General Hospital
Query!
Address
Daws Road
Daw Park SA 5041
Query!
Country
Australia
Query!
Secondary sponsor category [1]
256095
0
None
Query!
Name [1]
256095
0
Query!
Address [1]
256095
0
Query!
Country [1]
256095
0
Query!
Other collaborator category [1]
1209
0
University
Query!
Name [1]
1209
0
Flinders University
Query!
Address [1]
1209
0
2 Sturt Rd
Bedford Park SA 5042
Query!
Country [1]
1209
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
258837
0
Repatriation General Hospital Ethics Committee
Query!
Ethics committee address [1]
258837
0
Daws Road Daw Park SA 5041
Query!
Ethics committee country [1]
258837
0
Australia
Query!
Date submitted for ethics approval [1]
258837
0
30/10/2007
Query!
Approval date [1]
258837
0
Query!
Ethics approval number [1]
258837
0
Query!
Summary
Brief summary
Chronic shoulder pain is a common and distressing symptom for a large number of people with motor neurone disease. Treatments which are sometimes used for this problem include physiotherapy, pain killers and injections into the shoulder. Unfortunately, despite these treatments the pain frequently is not well controlled. Recently, a number of rheumatologists around the world have been using an injection to numb the nerve that supplies pain fibres to the shoulder in. This nerve is the suprascapular nerve. The results of studies to date have proven that this form of therapy is safe and works effectively to reduce pain and improve function. However, more information is required to establish this as a useful additional treatment in people with MND. Researchers at the Repatriation Hospital (Dr Michael Shanahan, Dr Peter Allcroft and Karen Glaetzer) are studying this treatment to see whether it is effective in reducing pain in people with motor neurone disease. In order to establish whether the treatment is effective in this group, we are performing a trial where we inject around the nerve at a point just above the shoulder blade with a mixture of local anaesthetic and anti-inflammatory steroid and then assess whether this helps to reduce the pain. We then compare the result of the injection with a group of people who do not receive the active injection, but rather a placebo injection of sterile normal saline (salt water). Placebo injections are an accepted practice to ascertain if the improvement in pain is due to the medication used or just the process of injecting into the nerve. We are inviting you to be involved
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
31054
0
Query!
Address
31054
0
Query!
Country
31054
0
Query!
Phone
31054
0
Query!
Fax
31054
0
Query!
Email
31054
0
Query!
Contact person for public queries
Name
14301
0
Karen Glaetzer
Query!
Address
14301
0
700 Goodwood Road
Daws Park SA 5041
Query!
Country
14301
0
Australia
Query!
Phone
14301
0
61 8 8275 1732
Query!
Fax
14301
0
61 8 82774957
Query!
Email
14301
0
[email protected]
Query!
Contact person for scientific queries
Name
5229
0
Dr Michael Shanahan
Query!
Address
5229
0
Daws Road
Daws Park SA 5041
Query!
Country
5229
0
Australia
Query!
Phone
5229
0
61 8 8276 9666
Query!
Fax
5229
0
Query!
Email
5229
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF